Format
Items per page
Sort by

Send to:

Choose Destination

Selected items

Items: 20

1.

Elevated serum immunoglobulin E (IgE): when to suspect hyper-IgE syndrome-A 10-year pediatric tertiary care center experience.

Joshi AY, Iyer VN, Boyce TG, Hagan JB, Park MA, Abraham RS.

Allergy Asthma Proc. 2009 Jan-Feb;30(1):23-7. doi: 10.2500/aap.2009.30.3193.

PMID:
19331717
2.

Hyper-IgE syndrome update.

Sowerwine KJ, Holland SM, Freeman AF.

Ann N Y Acad Sci. 2012 Feb;1250:25-32. doi: 10.1111/j.1749-6632.2011.06387.x. Epub 2012 Jan 23. Review.

3.

Autosomal dominant STAT3 deficiency and hyper-IgE syndrome: molecular, cellular, and clinical features from a French national survey.

Chandesris MO, Melki I, Natividad A, Puel A, Fieschi C, Yun L, Thumerelle C, Oksenhendler E, Boutboul D, Thomas C, Hoarau C, Lebranchu Y, Stephan JL, Cazorla C, Aladjidi N, Micheau M, Tron F, Baruchel A, Barlogis V, Palenzuela G, Mathey C, Dominique S, Body G, Munzer M, Fouyssac F, Jaussaud R, Bader-Meunier B, Mahlaoui N, Blanche S, Debré M, Le Bourgeois M, Gandemer V, Lambert N, Grandin V, Ndaga S, Jacques C, Harre C, Forveille M, Alyanakian MA, Durandy A, Bodemer C, Suarez F, Hermine O, Lortholary O, Casanova JL, Fischer A, Picard C.

Medicine (Baltimore). 2012 Jul;91(4):e1-19. doi: 10.1097/MD.0b013e31825f95b9.

4.

Mutations in STAT3 and diagnostic guidelines for hyper-IgE syndrome.

Woellner C, Gertz EM, Schäffer AA, Lagos M, Perro M, Glocker EO, Pietrogrande MC, Cossu F, Franco JL, Matamoros N, Pietrucha B, Heropolitańska-Pliszka E, Yeganeh M, Moin M, Español T, Ehl S, Gennery AR, Abinun M, Breborowicz A, Niehues T, Kilic SS, Junker A, Turvey SE, Plebani A, Sánchez B, Garty BZ, Pignata C, Cancrini C, Litzman J, Sanal O, Baumann U, Bacchetta R, Hsu AP, Davis JN, Hammarström L, Davies EG, Eren E, Arkwright PD, Moilanen JS, Viemann D, Khan S, Maródi L, Cant AJ, Freeman AF, Puck JM, Holland SM, Grimbacher B.

J Allergy Clin Immunol. 2010 Feb;125(2):424-432.e8. doi: 10.1016/j.jaci.2009.10.059.

5.

Cutaneous manifestations of Hyper IgE syndrome.

Minegishi Y, Saito M.

Allergol Int. 2012 Jun;61(2):191-6. doi: 10.2332/allergolint.12-RAI-0423. Epub 2012 Mar 25. Review.

6.

Pathogenesis of hyper IgE syndrome.

Heimall J, Freeman A, Holland SM.

Clin Rev Allergy Immunol. 2010 Feb;38(1):32-8. doi: 10.1007/s12016-009-8134-1. Review.

PMID:
19452285
7.

Molecular mechanisms of the immunological abnormalities in hyper-IgE syndrome.

Minegishi Y, Saito M.

Ann N Y Acad Sci. 2011 Dec;1246:34-40. doi: 10.1111/j.1749-6632.2011.06280.x. Review.

PMID:
22236428
8.

STAT3 mutations correlated with hyper-IgE syndrome lead to blockage of IL-6/STAT3 signalling pathway.

He J, Shi J, Xu X, Zhang W, Wang Y, Chen X, Du Y, Zhu N, Zhang J, Wang Q, Yang J.

J Biosci. 2012 Jun;37(2):243-57.

PMID:
22581330
9.

Large deletions and point mutations involving the dedicator of cytokinesis 8 (DOCK8) in the autosomal-recessive form of hyper-IgE syndrome.

Engelhardt KR, McGhee S, Winkler S, Sassi A, Woellner C, Lopez-Herrera G, Chen A, Kim HS, Lloret MG, Schulze I, Ehl S, Thiel J, Pfeifer D, Veelken H, Niehues T, Siepermann K, Weinspach S, Reisli I, Keles S, Genel F, Kutukculer N, Camcioğlu Y, Somer A, Karakoc-Aydiner E, Barlan I, Gennery A, Metin A, Degerliyurt A, Pietrogrande MC, Yeganeh M, Baz Z, Al-Tamemi S, Klein C, Puck JM, Holland SM, McCabe ER, Grimbacher B, Chatila TA.

J Allergy Clin Immunol. 2009 Dec;124(6):1289-302.e4. doi: 10.1016/j.jaci.2009.10.038. Erratum in: J Allergy Clin Immunol. 2010 Mar;125(3):743. Kutuculer, Necil [corrected to Kutukculer, Necil].

10.

STAT3 mutations in the hyper-IgE syndrome.

Holland SM, DeLeo FR, Elloumi HZ, Hsu AP, Uzel G, Brodsky N, Freeman AF, Demidowich A, Davis J, Turner ML, Anderson VL, Darnell DN, Welch PA, Kuhns DB, Frucht DM, Malech HL, Gallin JI, Kobayashi SD, Whitney AR, Voyich JM, Musser JM, Woellner C, Schäffer AA, Puck JM, Grimbacher B.

N Engl J Med. 2007 Oct 18;357(16):1608-19. Epub 2007 Sep 19.

11.

Impaired T(H)17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome.

Milner JD, Brenchley JM, Laurence A, Freeman AF, Hill BJ, Elias KM, Kanno Y, Spalding C, Elloumi HZ, Paulson ML, Davis J, Hsu A, Asher AI, O'Shea J, Holland SM, Paul WE, Douek DC.

Nature. 2008 Apr 10;452(7188):773-6. doi: 10.1038/nature06764. Epub 2008 Mar 12.

12.

Dominant-negative mutations in the DNA-binding domain of STAT3 cause hyper-IgE syndrome.

Minegishi Y, Saito M, Tsuchiya S, Tsuge I, Takada H, Hara T, Kawamura N, Ariga T, Pasic S, Stojkovic O, Metin A, Karasuyama H.

Nature. 2007 Aug 30;448(7157):1058-62. Epub 2007 Aug 5.

PMID:
17676033
13.

Hyper IgE syndrome: an update on clinical aspects and the role of signal transducer and activator of transcription 3.

Paulson ML, Freeman AF, Holland SM.

Curr Opin Allergy Clin Immunol. 2008 Dec;8(6):527-33. doi: 10.1097/ACI.0b013e3283184210. Review.

PMID:
18978467
14.

Defective IL-10 signaling in hyper-IgE syndrome results in impaired generation of tolerogenic dendritic cells and induced regulatory T cells.

Saito M, Nagasawa M, Takada H, Hara T, Tsuchiya S, Agematsu K, Yamada M, Kawamura N, Ariga T, Tsuge I, Nonoyama S, Karasuyama H, Minegishi Y.

J Exp Med. 2011 Feb 14;208(2):235-49. doi: 10.1084/jem.20100799. Epub 2011 Feb 7.

15.

Role of omalizumab in a patient with hyper-IgE syndrome and review dermatologic manifestations.

Chularojanamontri L, Wimoolchart S, Tuchinda P, Kulthanan K, Kiewjoy N.

Asian Pac J Allergy Immunol. 2009 Dec;27(4):233-6.

16.

Deficiency of Th17 cells in hyper IgE syndrome due to mutations in STAT3.

Ma CS, Chew GY, Simpson N, Priyadarshi A, Wong M, Grimbacher B, Fulcher DA, Tangye SG, Cook MC.

J Exp Med. 2008 Jul 7;205(7):1551-7. doi: 10.1084/jem.20080218.

17.

A patient with tyrosine kinase 2 deficiency without hyper-IgE syndrome.

Kilic SS, Hacimustafaoglu M, Boisson-Dupuis S, Kreins AY, Grant AV, Abel L, Casanova JL.

J Pediatr. 2012 Jun;160(6):1055-7. doi: 10.1016/j.jpeds.2012.01.056. Epub 2012 Mar 7. Erratum in: J Pediatr. 2012 Nov;161(5):974. J Pediatr. 2013 Mar;162(3):658.

18.

New mechanism of oral immunity to mucosal candidiasis in hyper-IgE syndrome.

Conti HR, Baker O, Freeman AF, Jang WS, Holland SM, Li RA, Edgerton M, Gaffen SL.

Mucosal Immunol. 2011 Jul;4(4):448-55. doi: 10.1038/mi.2011.5. Epub 2011 Feb 23.

19.

Hyper-IgE syndrome.

Minegishi Y.

Curr Opin Immunol. 2009 Oct;21(5):487-92. doi: 10.1016/j.coi.2009.07.013. Epub 2009 Aug 28. Review.

PMID:
19717292
20.

Defects in Jak-STAT-mediated cytokine signals cause hyper-IgE syndrome: lessons from a primary immunodeficiency.

Minegishi Y, Karasuyama H.

Int Immunol. 2009 Feb;21(2):105-12. doi: 10.1093/intimm/dxn134. Epub 2008 Dec 15. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk